BAVARIAN NORDIC R/I S/ADR by Bavarian Nordic A/S (BVNRY) Stock Price, Quote, News & History

SPY766.65 QQQ738.93+0.33%BTC/USD84,037.27+0.70%DIA514.78+0.15%GLD380.86+0.78%TLT78.78+0.20%

BAVARIAN NORDIC R/I S/ADR by Bavarian Nordic A/S (BVNRY) Stock Price, Quote, News & History

BVNRYOTCPK

Trade with Public

$11.09

0.05450.49%

At close: Sep 25, 5:00 PM EST

$10.95

-0.09-0.82%

Pre-Market: 5:00 PM EST

OverviewNews Financials Sentiment Compare

Key Statistics

Open

$11.09

Volume / Avg.

0 / 2.95K

Day Range

- - -

52 Wk Range

8.67 - 13.00

Market Cap

P/E Ratio

11.27

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Bavarian Nordic A/S News

UK Secures Additional Doses Of Bavarian Nordic Mpox Vaccine To Combat New Variant Threat

The UK government has purchased 150,000 mpox vaccine doses from Bavarian Nordic, enhancing its response to clade I mpox, while partnering with WHO and UNICEF.

Vandana Singh

Moderna's Investigational Mpox Vaccine More Effective Than Current Approved Shot, Animal Study Shows

Moderna is conducting a Phase 1/2 trial of mRNA-1769, a potential mpox vaccine for adults. Early research shows it may outperform Bavarian Nordic's Jynneos in reducing severe disease in monkeys.

Vandana Singh

Mpox Vaccines: Challenges Persist as Congo Receives First Batch Of Doses Almost 2 Years After It Declared Epidemic

The European Commission's first delivery of mpox vaccines to Congo aims to combat the outbreak, despite challenges in distribution and approval.

Vandana Singh

WHO Seeks $135M In Funding To Fight Mpox: Outbreak 'Can Be Controlled, And Can Be Stopped'

To fight the mpox outbreak in Africa, the World Health Organization calls for funding help for its six-month plan.

Chris Katje

Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain

Labcorp considers boosting its mpox testing capacity as the WHO declares a global health emergency. Companies like Roche and Quest Diagnostics are also monitoring demand and expanding testing services.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

1.44B

Investing Cash Flow (TTM)

-1.48B

Financing Cash Flow (TTM)

-405.24M

Free Cash Flow (TTM)

1.14B

Capital Expenditure (TTM)

-298.51M

Net Change in Cash (TTM)

-443.96M

Valuation Metrics

Enterprise Value

$2.17B

PE Ratio (TTM)

11.27

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

2.74

PB Ratio (TTM)

1.25

Earnings Yield % (TTM)

8.87%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

5.24

Price / EBITDA (TTM)

6.38

Price / Free Cash Flow (TTM)

15.23

Book Value / Share

$8.90

Company Debt

Total Debt

$11.96M

LT Debt

$9.81M

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$2.13M

Total Cash

$776.68M

Debt to Equity

0.01

Issuance of Debt (TTM)

-$2.13M

Repayment of Debt (TTM)

-$2.13M

Key Statistics

Open

$11.09

Volume / Avg.

0 / 2.95K

Day Range

- - -

52 Wk Range

8.67 - 13.00

Market Cap

P/E Ratio

11.27

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

Health Care

Industry

Biotechnology

Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The group is a supplier of mpox and smallpox vaccines to governments to enhance public health preparedne...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

FAQ

How do I buy BAVARIAN NORDIC R/I S/ADR by Bavarian Nordic A/S (BVNRY) stock?

You can purchase shares of BAVARIAN NORDIC R/I S/ADR by Bavarian Nordic A/S (OTCPK:BVNRY) through any online brokerage.

View our list of the best stock brokerages

Who are BAVARIAN NORDIC R/I S/ADR by Bavarian Nordic A/S (BVNRY) competitors?

There are no as such competitors for BAVARIAN NORDIC R/I S/ADR by Bavarian Nordic A/S.

What is the forecast, or price target, for BAVARIAN NORDIC R/I S/ADR by Bavarian Nordic A/S (BVNRY) stock?

There is no analysis for BAVARIAN NORDIC R/I S/ADR by Bavarian Nordic A/S to provide a consensus price target.

What is the current price for BAVARIAN NORDIC R/I S/ADR by Bavarian Nordic A/S (BVNRY)?

The stock price for BAVARIAN NORDIC R/I S/ADR by Bavarian Nordic A/S (OTCPK: BVNRY) is $11.0945 last updated September 28, 2026 at 9:45 AM EDT.

Does BAVARIAN NORDIC R/I S/ADR by Bavarian Nordic A/S (BVNRY) pay a dividend?

There are no upcoming dividends for BAVARIAN NORDIC R/I S/ADR by Bavarian Nordic A/S.

When is BAVARIAN NORDIC R/I S/ADR by Bavarian Nordic A/S (OTCPK:BVNRY) reporting earnings?

BAVARIAN NORDIC R/I S/ADR by Bavarian Nordic A/S does not have any upcoming earnings scheduled.

Is BAVARIAN NORDIC R/I S/ADR by Bavarian Nordic A/S (BVNRY) going to split?

There is no upcoming split for BAVARIAN NORDIC R/I S/ADR by Bavarian Nordic A/S.

What sector and industry does BAVARIAN NORDIC R/I S/ADR by Bavarian Nordic A/S (BVNRY) operate in?

BAVARIAN NORDIC R/I S/ADR by Bavarian Nordic A/S is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.